This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Saller, B. Articles by Lu, M. Search for Related Content PubMed PubMed Citation Articles by Saller, B. Articles by Lu, M.

RT-PCR-Based Detection of Circulating Calcitonin-Producing Cells in Patients with Advanced Medullary Thyroid Cancer

Division of Endocrinology, Department of Internal Medicine, Department of Clinical Chemistry (K.H., M.B.), and Institute of Virology (M.R., M.L.), University of Essen, 45122 Essen, Germany

Address all correspondence and requests for reprints to: B. Saller, M.D., Division of Endocrinology, Department of Medicine, University of Essen, Hufelandstrasse 55, 45122 Essen, Germany. E-mail: bernhard.saller{at}uni-essen.de

In patients with medullary thyroid carcinoma (MTC) the clinical course of disease ranges from rapid tumor progression to long-lasting stable disease. The purpose of the present study was to investigate whether circulating tumor cells can be detected in the peripheral blood of patients with MTC by RT-PCR targeted to calcitonin (CT) mRNA and whether the results of this method are correlated with disease manifestation and metastatic potential. Blood samples from 19 consecutive patients with MTC and elevated CT levels were analyzed. Four had newly diagnosed MTC, and 15 patients had undergone total thyroidectomy. Six of 19 patients had detectable CT mRNA by RT-PCR. CT levels in the CT mRNA-positive patients were significantly higher than those in CT mRNA-negative patients [2,239–265,313 pg/ml; median 80,921 pg/ml (n = 6) vs. 70–46,787 pg/ml; median, 932 pg/ml (n = 13); P = 0.006]. CT mRNA was detectable in 5 of 8 patients with distant metastases, in 1 of 6 patients with local/regional lymph node metastases, but in none of the patients with newly diagnosed, organ-confined MTC (n = 2) or surgically treated MTC without tumor manifestation by various imaging studies (n = 3). In peripheral blood from 10 healthy volunteers and 21 patients with benign thyroid nodules, no CT RNA could be detected. In conclusion, an RT-PCR-based procedure was established to detect circulating CT-producing cells in the peripheral blood of patients with MTC. RT-PCR results seem to reflect tumor spread and aggressiveness and thus may help with early identification of patients with disseminated and rapidly progressive disease.

This work was supported by a grant from Forum Schilddrüse e.V. (to B.S.).

Abbreviations: CT, Calcitonin; MTC, medullary thyroid carcinoma.

This article has been cited by other articles:

				E. Mirallie, J. P. Vuillez, S. Bardet, E. Frampas, B. Dupas, L. Ferrer, A. Faivre-Chauvet, A. Murat, B. Charbonnel, J. Barbet, et al. High Frequency of Bone/Bone Marrow Involvement in Advanced Medullary Thyroid Cancer J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 779 - 788. [Abstract] [Full Text] [PDF]